Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.0B | 4.0B | 4.1B | 4.0B |
Cost of revenue | 2.3B | 2.3B | 2.4B | 2.4B |
Gross profit | 1.7B | 1.7B | 1.7B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 417M | 439.3M | 406M | 395.1M |
Other operating expenses | 28M | 26.9M | 26.7M | 26.7M |
Operating income | 806M | 812.6M | 854.6M | 818.1M |
Non operating interest income | ||||
Income | 2M | 1.6M | 4.3M | 1.6M |
Expense | 140M | 133.2M | 138.2M | 128.3M |
Other income expense | -3M | -148.3M | -74.2M | -37.4M |
Pretax income | 665M | 532.7M | 646.5M | 654M |
Tax provision | 170M | 20.2M | 80.6M | 142.1M |
Net income | 495M | 512.5M | 565.9M | 511.9M |
Basic EPS | 1.6 | 1.6 | 1.8 | 1.6 |
Diluted EPS | 1.6 | 1.6 | 1.8 | 1.6 |
Basic average shares | 313M | 313.4M | 314M | 314.9M |
Diluted average shares | 313.3M | 313.8M | 314.4M | 315.2M |
EBITDA | 1.3B | 1.1B | 1.2B | 1.2B |
Net income from continuing op. | 495M | 512.5M | 565.9M | 511.6M |
Minority interests | 0 | -500K | -200K | -400K |
Preferred stock dividends | — | — | — | — |